
AI Integration in the Fight Against Age-Related Macular Degeneration
Wen Hwa Lee, CEO and Chief Scientist at AAAMD, discusses the use of AI in ophthalmology and drug discovery. He started as a molecular biologist and joined AAAMD to develop new approaches to slow down AMD. Challenges in utilizing AI in healthcare and ophthalmology include data fragmentation and standardization, which AAAMD addresses through participant-centric data…